ChangYD, JungJW, Oberio-JassalR, et al..Edmonton Symptom Assessment Scale and clinical characteristics associated with cannabinoid use in oncology supportive care outpatients. J Natl Compr Canc Netw2019;17:1059–1064.
PergamSA, WoodfieldMC, LeeCM, et al..Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use. Cancer2017;123:4488–4497.
PergamSA, WoodfieldMC, LeeCM, .Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use. Cancer 2017;123:4488–4497.10.1002/cncr.30879)| false
van den Beuken-van EverdingenMH, HochstenbachLM, JoostenEA, et al..Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage2016;51:1070–1090.
van den Beuken-van EverdingenMH, HochstenbachLM, JoostenEA, .Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage 2016;51:1070–1090.10.1016/j.jpainsymman.2015.12.340)| false
National Academies of Sciences, Engineering, and Medicine. The health effects of cannabis and cannabinoids: current state of evidence and recommendations for research. Washington, DC: National Academies Press; 2017.
National Academies of Sciences, Engineering, and Medicine. The health effects of cannabis and cannabinoids: current state of evidence and recommendations for research. Washington, DC: National Academies Press; 2017.)| false
National Cancer Institute. Cannabis and cannabinoids (PDQ)-health professional version. Available at: https://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq. Accessed August 12, 2019.)| false